表紙
市場調查報告書

細菌性陰道炎:全球臨床實驗檢討

Bacterial Vaginosis Global Clinical Trials Review, H2, 2019

出版商 GlobalData 商品編碼 244195
出版日期 內容資訊 英文 159 Pages
訂單完成後即時交付
價格
Back to Top
細菌性陰道炎:全球臨床實驗檢討 Bacterial Vaginosis Global Clinical Trials Review, H2, 2019
出版日期: 2019年09月05日內容資訊: 英文 159 Pages
簡介

本報告提供全球細菌性陰道炎治療藥臨床實驗相關調查,提供您各地區的臨床試驗數資料,實驗階段,實驗狀況,採用主題及各類型贊助企業的臨床實驗資料、中斷(暫時停止,廢止,截止)的實驗清單等。

簡介

  • 細菌性陰道炎
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 前五名國家的臨床實驗數量; 中東/非洲地區
    • 主要國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量

Phase別臨床實驗數量: G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量

Phase別臨床實驗數量: E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗

一定期間所採用的受驗者人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 細菌性陰道炎 治療藥

有潛力的藥劑

  • 最新臨床實驗新聞

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Starpharma Holdings Limited
    • Symbiomix Therapeutics, LLC
    • Merck & Co., Inc.
    • Ferring International Center S.A.
    • AmVac AG
    • Osel Inc.
    • Mission Pharmacal Company
    • Actavis plc
    • Arun Pharmaceuticals Limited
    • Alfa Wassermann S.p.A
  • 有代表性的研究機關/醫院臨床實驗概要
    • University of Alabama at Birmingham
    • University of Pittsburgh
    • Shiraz University of Medical Sciences
    • Lawson Health Research Institute
    • Centers for Disease Control and Prevention
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • Mount Sinai Hospital
    • The National Institute of Allergy and Infectious Diseases
    • Ahvaz Jundishapur University of Medical Sciences

5大臨床實驗簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC5750CTIDB

GlobalData's clinical trial report, "Bacterial Vaginosis Global Clinical Trials Review, H2, 2019" provides an overview of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) clinical trials scenario. This report provides top line data relating to the clinical trials on End-Stage Kidney Disease (End-Stage Renal Disease or ESRD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
  • Top Five Countries Contributing to Clinical Trials in Europe 13
  • Top Countries Contributing to Clinical Trials in North America 14
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
  • Top Countries Contributing to Clinical Trials in Central and South America 16
  • Clinical Trials by G7 Countries: Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials 17
  • Clinical Trials by Phase in G7 Countries 19
  • Clinical Trials in G7 Countries by Trial Status 20
  • Clinical Trials by E7 Countries: Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials 22
  • Clinical Trials by Phase in E7 Countries 24
  • Clinical Trials in E7 Countries by Trial Status 25
  • Clinical Trials by Phase 27
  • In Progress Trials by Phase 28
  • Clinical Trials by Trial Status 29
  • Clinical Trials by End Point Status 31
  • Subjects Recruited Over a Period of Time 32
  • Clinical Trials by Sponsor Type 33
  • Prominent Sponsors 34
  • Top Companies Participating in Bacterial Vaginosis Therapeutics Clinical Trials 36
  • Prominent Drugs 37
  • Latest Clinical Trials News on Bacterial Vaginosis 38
  • Aug 08, 2019: Dare announces presentation of positive clinical findings for vaginal administration of novel formulation of clindamycin phosphate for the treatment of bacterial vaginosis at the 2019 Annual Meeting of the Infectious Diseases Society for Obstetrics and Gynecology 38
  • Clinical Trial Profile Snapshots 39

Appendix 158

  • Abbreviations 158
  • Definitions 158
  • Research Methodology 159
  • Secondary Research 159
  • About GlobalData 160
  • Contact Us 160
  • Source 161

List of Tables

  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Region, 2019* 8
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
  • Bacterial Vaginosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
  • Bacterial Vaginosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
  • Bacterial Vaginosis Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
  • Bacterial Vaginosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
  • Bacterial Vaginosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2019* 16
  • Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, G7 Countries (%), 2019* 18
  • Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
  • Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 21
  • Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, E7 Countries (%), 2019* 23
  • Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24
  • Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 26
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Phase, 2019* 27
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 28
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 30
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 31
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 32
  • Bacterial Vaginosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 33
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 35
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 37

List of Figures

  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
  • Bacterial Vaginosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
  • Bacterial Vaginosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
  • Bacterial Vaginosis Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
  • Bacterial Vaginosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15
  • Bacterial Vaginosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2019* 16
  • Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, G7 Countries (%), 2019* 17
  • Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
  • Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
  • Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, E7 Countries (%), 2019* 22
  • Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24
  • Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Phase (%), 2019* 27
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 28
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 31
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 32
  • Bacterial Vaginosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 33
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 37
  • GlobalData Methodology 159
Back to Top